Literature DB >> 16913976

Tonsillar abscess formation due to herpes simplex type-1 in a severely immunocompromised stem cell transplant patient with chronic myeloid leukemia.

C Gonen1, A Uner, Y Cetinkaya, G Hascelik, I Haznedaroglu.   

Abstract

Herpes simplex virus (HSV) causes life-threatening infections in immunocompromised patients such as transplant recipients and patients with hematologic malignancies. We herein describe the case of a patient with chronic myeloid leukemia blastic transformation who developed severe herpetic tonsillitis complicated by tonsillar abscess formation. Abscess formation was determined by computed tomography, whereas tonsillitis due to HSV was confirmed by pathologic and immunohistochemical examinations of the tonsillar biopsy. For molecular confirmation, HSV DNA was amplified by LightCycler PCR and type (HSV-1) determined by melting point analysis. The patient responded promptly to antiviral treatment and there were no signs of recurrent infection at the follow-up. To our knowledge, this case is unique for being the first case of tonsillar abscess formation due to HSV-1, also emphasizing the importance of herpetic infections in the differential diagnosis of oropharyngeal small-sized lesions in the immunocompromised patient population.

Entities:  

Mesh:

Year:  2006        PMID: 16913976     DOI: 10.1111/j.1399-3062.2006.00131.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  3 in total

1.  Necrotizing herpes-simplex virus tonsillitis mimicking peritonsillar abscess.

Authors:  Cédric Hirzel; Susanne Nueesch; Thomas Wendland; Rupert Langer
Journal:  Infection       Date:  2015-07-21       Impact factor: 3.553

2.  Acute necrotizing herpetic tonsillitis: a report of two cases.

Authors:  Walaa M Borhan; Mohammed A Dababo; Lester D R Thompson; M Saleem; N Pashley
Journal:  Head Neck Pathol       Date:  2013-12-14

3.  Herpes simplex induced necrotizing tonsillitis in an immunocompromised patient with ulcerative colitis.

Authors:  Laura Jansen; Xander G Vos; Mark Löwenberg
Journal:  World J Clin Cases       Date:  2016-02-16       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.